The chemopreventive agents 4-HPR and DFMO inhibit growth and induce apoptosis in uterine leiomyomas
- 1 March 2004
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 190 (3) , 686-692
- https://doi.org/10.1016/j.ajog.2003.09.048
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomataFertility and Sterility, 2002
- Insights from gene arrays on the development and growth regulation of uterine leiomyomataFertility and Sterility, 2002
- Polyamine depletion arrests cell cycle and induces inhibitors p21Waf1/Cip1, p27Kip1, and p53 in IEC-6 cellsAmerican Journal of Physiology-Cell Physiology, 1999
- Polyamines are important for attachment of IEC-6 cells to extracellular matrix.American Journal of Physiology-Gastrointestinal and Liver Physiology, 1997
- Cultured Human Uterine Smooth Muscle Cells Are Retinoid ResponsiveExperimental Biology and Medicine, 1997
- N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinomaCarcinogenesis: Integrative Cancer Research, 1995
- Retinoic acid inhibits estrogen-induced uterine stromal and myometrial cell proliferation.Endocrinology, 1995
- Hysterectomy in the United States, 1988-1990Obstetrics & Gynecology, 1994
- Relationships among uterine growth, ornithine decarboxylase activity and polyamine levels: studies with estradiol and antiestrogensMolecular and Cellular Endocrinology, 1984
- Dissociated regulation of growth and ornithine decar☐ylase activity by estrogen in the rat uterusBiochemical and Biophysical Research Communications, 1984